Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ARGSQ: BK PLAN effective. All shares cancelled.
https://otce.finra.org/otce/dailyList?viewType=Deletions
Can you please elaborate? What purchase are you referring to? TIA
ARGS changed to ARGSQ, bankruptcy:
http://otce.finra.org/DLSymbolNameChanges
Somebody's interested, big 50k spike in volume last 30 minutes.
Is this company working on anything?
Thanks for that, hope we get some kind of update. Not sure what they're working on now.
Hope so. My average price is WAY up there. They report in Nov.
September trading volume is up, more consistent day by day. Wondering if there's anything going on?
Hmm... .17 cents post-rs now.
READ BOLD.VERIFY ON LINK.
https://www.otcmarkets.com/stock/ARGS/security
ARGS SECURITY DETAILS
Share Structure
Market Cap
1,715,051
06/05/2018
Authorized Shares
200,000,000
06/04/2018
Outstanding Shares
10,586,737
06/04/2018
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
9,013,949
06/04/2018
Float
6,776,900
02/28/2018
6.6mil float??? Don't think so.
I AGREE.IF IT GETS VOLUME WITH ONLY 6,6 MILLION IN THE FLOAT,IT WILL GO BALLISTIC.THERE IS A HUGE SHORT IN THE STOCK.I AM WAITING FOR AN EXCUSE TO CREATE A SHORT COVER,AND HAVE SHORTY CHASE ALL THE WAY TO .45.SOME UPDATE OF NEWS WILL DO THE TRICK.
ARGS With $1.9/share cash, company looking for Reverse Merger or to be acquired. beaten down hard but currently having huge upside from current pps:
This is from the May15, 2018 10Q:
Based on a review of the status of its internal programs, resources and capabilities, the Company is exploring a wide range of strategic alternatives that may include a potential merger or sale of the Company, among other potential alternatives. The Company has retained Stifel, Nicolaus & Company, Incorporated (“Stifel”) to serve as its financial advisor in the process. There can be no assurance that the Company will be able to enter into such a transaction or transactions on a timely basis, on terms that are favorable to the Company, or at all.
SHORTS ARE SHORTING.WITH THE HELP OF THE POS MMs.THEY WILL GET TRAPPED.THE NETS ARE IN.THEY DO NOT KNOW WHO THEY F WITH.
Is there a new board? It's awfully quiet on this one
THE PLANET WHEN I SAID NITE WILL DO WHAT EXACTLY WHAT HE IS DOING TODAY:)))
LIKE A SONG.DOWN TO .18 ALREADY.IT WAS TRADING AT .30S WHEN I CALLED IT.
SMART MONEY BAILED.LOL.
ORCA Member Level Friday, 04/20/18 10:03:32 AM
Re: declaes post# 1967 0
Post #
1968
of 1973
WHEN IT TRADES ON OTC MONDAY,NITE WILL RIP IT APART.PROBABLY DOWN TO .13 TO .15 AREA IMO.
Going Up from here dudes ?
ARGS delisted from Nasdaq to OTC effective April 25, 2018
http://otce.finra.org/DailyList
Looks like you're going to be right except it'll be Wednesday look at the pre trading hours
WHEN IT TRADES ON OTC MONDAY,NITE WILL RIP IT APART.PROBABLY DOWN TO .13 TO .15 AREA IMO.
8mil? 15mil imo. At this point.
?$args will go up today. $.38-$.40 easy. 8 million shares only. ?
ARGS~~bad news,,*Argos Therapeutics Says Trading In Common Stock Will Be Transferred From Nasdaq To OTCQB On Apr. 23, '18
Benzinga
Some have good opinions, drug doesn't appear to be effective; appears you live longer without it if i'm understanding it right.
BUT, do your own analysis and DD; this is not to be seen as any type of advice, just my uneducated and uninformed opinion.
imo, this was their big play and it is a bust, possibly args can be a target for write-off to offset gains elsewhere.
They should deeply analyze, maybe some other application would be beneficial; that statement about "increase in antigen-specific memory T cells" could be something worth looking into.
It is possible that buyers and bids may dwindle and only bag holders, scammers, suckers, and dreamers will be left.
Yep, no reason to hold on here anymore imo. What a hit. All my yearprofit and more gone on this stock. I will remember thisone a long time FOK!
Wow, what a POS!!!
I feel bad for all who have lost money here.
I would not be surprised to learn that they have been trying to sell the Company for the last 6 months or longer.
In my opinion, they will end up going bankrupt and any asset with value will be sold off in Bankruptcy Court for pennies on the dollar.
You really think so? I´ve posted lots of BS here full of hope during the last months - stupid me! They brought all horrible news into one PR. For reason imo. It´s done! They had a chance to perhaps put this into a time frame of two weeks or similar. But they sent lots of hopeful updates and hints to sell as many shares as possible. And didn´t file chapter 11 to sell more shares right now. They had a clear plan to cheat all of us! I´ve seen several bios, this here is one of the worst. Planned fraud!
So better don´t tell people this is going to see a buyout after changing to OTC. If buyout would´ve been the plan they could do it in several other, much more reasonable ways. All I know is I need to take the huge loss as a man (still standing!!!). NEVER hold through a RS, even worse to hold shares changing to OTC.
All imo - bye bye
With the move to the otc next week, i would wait for now. There is some value left, the only question is, will someone buy?
could bounce here. Buy some.
news and share drop not fully disseminated. Best to wait until end of day Fri. or Mon. to buy -- there will be more selling into any strength as you can see.
Now is the time time buy!!!!!! I just loaded up!!!!!! Thanks for the cheap shares!!!! $$$$$$$$
It's RIP, not much left but a gamble in which the olds are incredible.
grich- so be it, RIP
Ive seen this movie with OHRP. It dropped from $2 to 40 cents in one day and now it's around 23 cents.
Args appears to be shortening lives and phase 2 CT was trash as they had no placebo. They compared phase 2 results with old life expectancy charts while SOC was improving.
Spent 3 hours reviewing data last Saturday for both indications.
Placebos are very helpful as lifestyle changes can impact old life expectancy statistics.
WHO IS THE NEXT?=
ARGS
ANTH
AKER
AYTU.......
THE "A" is damn!!!
AGS 004 failed 3 years ago and why should one expect anything else? It was big governments money so they kept it moving.
https://www.fiercebiotech.com/r-d/argos-tanks-as-its-hiv-immunotherapy-flunks-phase-ii
Sorry & Sad
they missed it now, obviously.
So the HIV AGS-004 is left to be traded on OTCQB.
What a bummer.
Got out at .65.... oh well. Lesson learned
Wouldn´t over analyze pre market with 3k shares traded. Headed in the right direction soon imo!
1.14 x 1.22 pre market. Maybe someone got a whiff of something
I´m not 100% secure in translating all these special medical terms. What do you think or what have you been trying to point out?
Sounds like 100% written for ARGS...
what do you guys think of this approval? Thoughts more then welcome.
https://www.mdedge.com/oncologypractice/article/163587/renal-cell-carcinoma/fda-approves-immunotherapy-combo-advanced-rcc
D
Followers
|
55
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1990
|
Created
|
06/28/14
|
Type
|
Free
|
Moderators |
- Feb '17 DMC Recommends Discontinuation of AGS-003 ADAPT Trial
- March '17 Communicated BK risk
- April '18 AGS-003 ADAPT Trial Perspective to Continue Trial
- May '17 FDA Agrees on AGS-003 ADAPT Continuation and will Review Protocol Amendment
- June '17 $5M funding round - BK risk removed, company continues
- July '17 AGS-004 Open-Label Ph1 HIV Trial Reaches PE, 6 pt, 2-fold increase
- Sep '17 AGS-004 Phase 2 HIV eradication trial : Dosing First Patient
- Sep '17 AGS-003 ADAPT Trial Interim Data Discussion @ ESMO
- Nov '17 Lummy made a $1.5M milestone payment
- Dec '17 CC Transcript
- Jan '18 Lummy's $1.5M 0.375M shares @ $4/sh equity investment, to be closed & converted on 2018-03-07
- Jan '18 RS 1:20
- Feb '18 424B5 of $200M Shelf 333-215480: $15M Equity Sales via Cowen, ATM
- Feb '18 Option to license PD1 Checkpoint Inhibitors for other/more drug variants (?)
- Feb '18 Received a patent for AGS-004 production, their HIV drug
- Early 2018 AGS-004 Pilot Trial 12 patients, primary completion March 2018. Positive data from 6 patients published.Current EV 2018-03-16 8-K
Goes on OTCQB on 4/23 '18
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |